Authors:
JOHNSTON PS
FEIG PU
CONIFF RF
KROL A
DAVIDSON JA
HAFFNER SM
Citation: Ps. Johnston et al., LONG-TERM TITRATED-DOSE ALPHA-GLUCOSIDASE INHIBITION IN NON-INSULIN-REQUIRING HISPANIC NIDDM PATIENTS, Diabetes care, 21(3), 1998, pp. 409-415
Authors:
JOHNSTON PS
FEIG PU
CONIFF RF
KROL A
KELLEY DE
MOORADIAN AD
Citation: Ps. Johnston et al., CHRONIC TREATMENT OF AFRICAN-AMERICAN TYPE-2 DIABETIC-PATIENTS WITH ALPHA-GLUCOSIDASE INHIBITION, Diabetes care, 21(3), 1998, pp. 416-422
Authors:
JOHNSTON PS
LEBOVITZ HE
CONIFF RF
SIMONSON DC
RASKIN P
MUNERA CL
Citation: Ps. Johnston et al., ADVANTAGES OF ALPHA-GLUCOSIDASE INHIBITION AS MONOTHERAPY IN ELDERLY TYPE-2 DIABETIC-PATIENTS, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1515-1522
Authors:
DAVIS PF
HE Y
FURNEAUX RH
JOHNSTON PS
RUGER BM
SLIM GC
Citation: Pf. Davis et al., INHIBITION OF ANGIOGENESIS BY ORAL INGESTION OF POWDERED SHARK CARTILAGE IN A RAT MODEL, Microvascular research, 54(2), 1997, pp. 178-182
Citation: Ps. Johnston, ISRAEL BENEFICENT-DEAD - ANCESTOR CULT AND NECROMANCY IN ANCIENT ISRAELITE RELIGION AND TRADITION - SCHMIDT,BB, Journal of theological studies, 47, 1996, pp. 169-172
Citation: Rf. Coniff et al., LONG-TERM EFFECTS OF THE ALPHA-GLUCOSIDASE INHIBITOR MIGLITOL (BAY-M-1099) IN NIDDM PATIENTS TREATED WITH MAXIMAL-DOSE SULFONYLUREA (SFU), Diabetes, 45, 1996, pp. 815-815
Authors:
JOHNSTON PS
SANTIAGO JV
CONIFF RF
PISUNYER FX
HOOGWERF BJ
KROL A
Citation: Ps. Johnston et al., EFFECTS OF THE CARBOHYDRASE INHIBITOR MIGLITOL IN SULFONYLUREA-TREATED NIDDM PATIENTS, Diabetes care, 17(1), 1994, pp. 20-29
Citation: Ps. Johnston et Rf. Coniff, MIGLITOL (BAY M-1099) TREATMENT OF NIDDM PATIENTS TREATED WITH DIET AND MAXIMAL DAILY DOSES OF SULFONYLUREA (SFU), Diabetes, 42, 1993, pp. 79-79